• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Consumer

Capza acquires minority stake in Nutravalia

  • Ero Partsakoulaki
  • 22 June 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Capza has acquired a minority stake alongside the management in Nutravalia, a French laboratory specialising in food supplements and parapharmacy products.

The GP made the transaction via its Capza 5 Flex Equity Fund, which held its final close at its hard cap of EUR 700m in May 2021, according to Unquote Data.

Nutravalia is the 14th transaction of the fund and Capza’s 35th transaction in the health and wellness sector. A debt package backing the deal was provided by Crédit du Nord, LCL, and Arkéa, according to a press release.

Nutravalia

  • DEAL:

    Expansion

  • LOCATION:

    France

  • SECTOR:

    Pharmaceuticals

  • FOUNDED:

    2015

  • TURNOVER:

    c. EUR 45 million by 2022

  • STAFF:

    50

Mergermarket had reported in March that the company was working with Sycomore on a sale, marketed off EUR 6m in EBITDA. 

The management will retain a reference shareholding, pursuing organic growth of brands in France, while considering international development and strategic acquisitions. The company aims to accelerate the development of its hair care brand, Luxéol, in France, to launch the brand internationally, starting with Spain and Italy.

“Nutravalia’s founders chose to partner with Capza as our pan-European footprint with offices in the south of Europe, Germany and Benelux would facilitate this strategic goal,” managing partner Maxence Radix told Unquote.

The company is also seeking to consolidate the position of its slimming brand 'Anaca3' in France, notably through a strong innovation pipeline and regular new product launches. The company will target organically new markets, such as the skincare segment, with new product development, according to Radix.

“We think of the investment strategy as two phases, with organic growth and new product development taking place during the first two to three years, followed by the M&A phase with opportunistic targets in France or Europe,” said Radix. “Of course, if we see an opportunity that cannot wait we’ll try to seize it.”

The company would welcome pitches from external advisors in the future as it is currently at an early stage of developing its investment strategy.

Capza foresees increasing consolidation in the pharmaceutical market in France, seeing more players coming to market following big players such as Havea, Cooper, and EA Pharma.

Nutravalia has developed an omnichannel distribution strategy, using digital technology to launch and develop its brands, before moving into pharmacies and parapharmacies. The business has experienced growth of over 54% per year on average, since 2015. It expects to achieve a turnover of about EUR 45m by 2022.

“Nutravalia’s business model with strong growth, high margin and cash conversion, as well as strong brand recognition, makes it a great fit for our Flex Equity Fund,” said Radix.

Company
Founded in 2015 by brothers Samuel and Michel Bouskila, Nutravalia designs, develops, and markets products dedicated to well-being and beauty (food supplements, cosmetics, shampoos). The group has launched two specialised brands that have rapidly entered the pharmacies and parapharmacies network: Luxéol in the hair care segment and Anaca3 in the slimming segment. Based in Mougins, near Cannes, France, Nutravalia employs around 50 people.

People
Nutravalia – Samuel Bouskila (president and founder); Michel Bouskila (managing director and founder).
Capza − Maxence Radix; Victoire Simon; Laure Tallon (partners).

Advisors
Nutravalia – Sycomore Corporate Finance François Vigne, Aurélien Singer, Quentin de Fréminville, Adrien Starck, Malo Grosso (M&A); Hogan Lovells Stéphane Huten, Paul Leroy, Florian Tranchecoste, Arnaud Biancheri, Luc Bontoux, Quentin de Donder, Ludovic Geneston, Maximilien Schmitt, Marion Guertault (legal); PwC Martin Naquet-Radiguet, Arnaud Stenger (financial DD); OC&C Stéphane Blanchard, Wassim Chraiki (strategic DD); PwC Eric Hickel, Edith Baccichetti, Bernard Borrely, Katia Gruzdova, Hélène Struve, Claire Rey, Hortense Muhorakeye, Clément Jouanolle (tax, fiscal and social DD).
Equity − Moncey Guillaume Giuliani, Marie Victoire James, Frédéric Bosc, David Malamed, Alexandre Bankowski, Jonathan Devillard, David Maréchal (legal); Oderis Thomas Claverie, Léo Paczek, Gauthier Sarre (financial DD); Indefi x Singulier David Toledano, François Beyssen (strategic DD); Moncey Guillaume Giuliani, Marie Victoire James, Frédéric Bosc, Alexandre Bankowski, Bonnie Brenier, Mathilde Cotillon, Anastasia Fleury (tax, fiscal and social DD).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Consumer
  • France
  • Expansion
  • France
  • Capzanine

More on Consumer

Plant-based healthcare supplements
3i sells Havea to BC-led consortium

BC Partners is acquiring the French natural healthcare group with co-investors PSP and National Pensions Services Investment Management

  • Consumer
  • 23 June 2022
Children apparel companies
3i to invest in Danish children's brand Konges Sløjd

Deal aims to support the baby and children apparel group expand in Asia and the US

  • Nordics
  • 21 June 2022
Sfoglia Torino produces frozen bakery goods
Mindful Capital hires adviser to sell Italian Frozen Food Holding

Vitale will guide the sponsor in an auction expected to launch between September and October

  • Exits
  • 21 June 2022
Italian fundraise
Alto preps new vehicle as Fund IV deployment nears completion

Italian investor is preparing for new fund investing in Italian SMEs specialising in consumer, industrial, services and pharma sectors.

  • Buyout
  • 14 June 2022

Latest News

Secondaries GPs expecting record 2022
  • Secondaries
Secondaries GPs expect record 2022 – Investec

Fifth Secondaries Market Report also reveals that 97% of secondaries investors are participating in GP-leds

  • 27 June 2022
Veterinary clinics
  • Buyouts
Eurazeo in exclusivity for Sevetys acquisition

French sponsor beats Ardian and Antin in race for a majority stake in French veterinary chain

  • 27 June 2022
Kirsten Connell and Maria Rotilu of Octopus Ventures
  • GPs
VC Profile: Octopus backs pre-seed ecocystem with fresh fund

Fund is headed by Kirsten Connell and Maria Rotilu and has extended its hard cap to GBP 15m following a first close

  • 27 June 2022
Net zero and carbon neutral concept
  • Exits
Bowmark backs Cornwall Insight buyout

BGF exits energy markets consultancy following minority stake investment in 2017

  • 27 June 2022
Back to Top

Most read

Secondaries GPs expecting record 2022
Secondaries GPs expect record 2022 – Investec
Veterinary clinics
Eurazeo in exclusivity for Sevetys acquisition
Kirsten Connell and Maria Rotilu of Octopus Ventures
VC Profile: Octopus backs pre-seed ecocystem with fresh fund
Net zero and carbon neutral concept
Bowmark backs Cornwall Insight buyout
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013